Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?

Decades of research have produced no effective method to prevent, delay the onset, or slow the progression of Alzheimer’s disease (AD). In contrast to these failures, acetylcholinesterase (AChE, EC 3.1.1.7) inhibitors slow the clinical progression of the disease and randomized, placebo-controlled tr...

Descripción completa

Detalles Bibliográficos
Autor principal: Moss, Donald E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279429/
https://www.ncbi.nlm.nih.gov/pubmed/32414155
http://dx.doi.org/10.3390/ijms21103438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279429/
https://www.ncbi.nlm.nih.gov/pubmed/32414155
http://dx.doi.org/10.3390/ijms21103438

Ejemplares similares